Navigation Links
Alimera Announces Positive Results From the Two Phase 3 FAME(TM) Trials of Iluvien(R) in Patients With Diabetic Macular Edema
Date:12/23/2009

s with the blurring of central vision or acute vision loss. The severity of this blurring may range from mild to profound loss of vision. The Wisconsin Epidemiologic Study of Diabetic Retinopathy found that over a 10-year period approximately 19% of diabetics studied were diagnosed with DME. Based on this study and the current U.S. diabetic population, Alimera estimates that there will be an incidence of approximately 340,000 cases of DME annually in the United States. As the population of people with diabetes increases, Alimera expects the annual incidence of diagnosed DME to increase as well.

About Iluvien®

Iluvien is an investigative, extended release intravitreal insert that Alimera is developing for the treatment of DME. Each Iluvien insert is designed to provide a therapeutic effect of up to 36 months by delivering sustained sub-microgram levels of fluocinolone acetonide (FA). Iluvien is inserted in the back of the patient's eye to a position that takes advantage of the eye's natural fluid dynamics. Iluvien is inserted with a device that employs a 25-gauge needle, which allows for a self-sealing wound.

About Alimera Sciences, Inc.

Alimera Sciences is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Presently the company is focused on diseases affecting the back of the eye, or retina. Its most advanced product candidate is Iluvien®, which is being developed for the treatment of diabetic macular edema, or DME.

Alimera is also pursuing the development, license and acquisition of rights to compounds and technologies with the potential to treat diseases of the eye that Alimera believes are not well treated by current therapies. Alimera has entered into agreements with Emory University, where by it acquired exclusive, worldwide rights under patent applications covering two classes of nicotin
'/>"/>

SOURCE Alimera Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Alimera Sciences Announces Presentation of Data From the 12-Month Interim Readout of the Human PK Iluvien(TM) Study at ARVO 2009 Annual Meeting
2. Alimera Sciences Iluvien(TM) Phase 3 Studies for DME Pass Final DSMB Review Prior to October Readout
3. Alimera Reports Favorable Safety and Efficacy Results From the 12-Month Interim Readout of the Human PK Iluvien(TM) Study
4. Alimera Reports Results From the Six-Month Interim Readout of the Human PK Iluvien(TM) Study
5. DSMB Again Supports Continuation of Alimera Sciences Phase 3 Clinical Trial of Iluvien(TM) for the Treatment of DME
6. Alimera Reports Results From the Three-Month Interim Readout of the Human PK Medidur(TM) FA Study
7. China Medicine Announces Changes to Management Team
8. PDI Announces New Pharmaceutical Services Business Win With a Top 5 Pharmaceutical Company
9. Jennerex Announces Presentations at Upcoming Conferences
10. Macomb County Announces Final 2009 H1N1 Clinic
11. Access MediQuip Announces Release of Partners in Focus Provider Portal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... April 21, 2015   Rock Creek Pharmaceuticals, Inc., ... focused on the treatment of chronic inflammatory disorders, announced ... to the Company,s Board of Directors with the recent ... a new director. Michael Mullan ... Pharmaceuticals, said, "Dr. Samuel,s experience in advancing biotechnology products ...
(Date:4/21/2015)... , April 21, 2015  Direct contracting continues ... as aptitude marks its second anniversary.  With over ... platform, single hospital entities, large integrated delivery systems ... that cover medical surgical items, clinical preference products ... cost effective - complementary contracting strategy, aptitude seeks ...
(Date:4/21/2015)... , April 21, 2015  Game-changing ... the latest being the European Commission,s ruling on ... global leader and champion of pharmaceutical supply ... of meeting these mandates and offers several tools ... many countries. From an upcoming webinar in May ...
Breaking Medicine Technology:Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 2Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 3Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 4Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 5Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 6Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 7Healthcare's first direct contracting market celebrates second anniversary 2Frequentz Gives the Global Pharmaceutical Supply Chain a Shoulder to Lean On as They Face Expanding Serialization Requirements 2Frequentz Gives the Global Pharmaceutical Supply Chain a Shoulder to Lean On as They Face Expanding Serialization Requirements 3
(Date:4/21/2015)... (PRWEB) April 21, 2015 The joint ... today it is opening its first freestanding emergency room ... Chandler, Arizona and will be licensed under Dignity Health ... Dignity Health and Adeptus Health joint venture. , Tim ... and Mercy Gilbert Medical Centers said the new facility ...
(Date:4/21/2015)... NJ & New York, NY (PRWEB) April 21, ... leading global provider of advanced delivery technologies and ... products, today announced the launch of ADVASEPT™ Lock, ... safe and efficient delivery of injectable medications. Easily ... combining a safe, convenient and functional container closure ...
(Date:4/21/2015)... Carinsurancehints.com has released a new blog ... impact on auto insurance prices . , ... prices. Clients should review their insurance options before deciding ... under several forms. Some of the popular policies provide ... compare online rates and find the best prices in ...
(Date:4/21/2015)... PA (PRWEB) April 21, 2015 This ... & Related Skin Types, Inc.® (FIRST) will publish a ... The campaign will run throughout the month of May ... It Matters to Someone." The positioning was chosen ... this rare skin disorder and to help support our ...
(Date:4/21/2015)... Carinsuranceshoppingsource.com has released a new blog ... insurance plans . , Comprehensive auto insurance is ... situations. The coverage limit can also be high and ... protect a car against fire damage, vandalism, theft and ... no longer difficult and it can help drivers find ...
Breaking Medicine News(10 mins):Health News:Dignity Health and Adeptus Health to Open First Freestanding Emergency Room in Chandler, Arizona 2Health News:Dignity Health and Adeptus Health to Open First Freestanding Emergency Room in Chandler, Arizona 3Health News:Catalent Announces the Expansion of its Advanced, Aseptic, Glass-Free Injectable Platform with New ADVASEPT™ Lock Delivery Technology 2Health News:Heavily Circulated Roads Can increase Auto Insurance Costs 2Health News:May is Ichthyosis Awareness Month. Use Your Voice. 2Health News:Comprehensive Auto Insurance Is An Important But Complex Policy 2
... Kiadis Pharma,announced today that its lead product ATIR ... Food and Drug Administration (FDA) as a therapy ... Disease (GvHD),following allogeneic bone marrow transplantation. ATIR is ... enter clinical phase III,studies in 2008. "This ...
... to treat high blood pressure and enlargement of ... caused by post-traumatic stress disorder, Alzheimer,s disease, depression ... antipsychotic medication, appears to block the increase of ... Science University and Portland Veterans Affairs Medical Center ...
... Scientists at Cold Spring Harbor Laboratory (CSHL) have developed a ... genome that is more powerful and more economical than methods ... to be a boon to many kinds of research, including ... genes implicated in major diseases such as cancer and schizophrenia. ...
... CV Therapeutics,Inc. (Nasdaq: CVTX ) today reported financial ... the quarter ended September 30, 2007, the Company reported a ... to a net loss of,$62.7 million, or $1.23 per share, ... per share, for the prior quarter ended June 30, 2007. ...
... and 6 ... other cities, RALEIGH, N.C., ... on the impact of new CPR techniques, the,results of which support the ... the study authors in a,presentation at the AHA,s Scientific Sessions on November ...
... Concise reporting would ensure validity of patient safety findings, group ... to be used as hospital safety rating tools have been ... the guidelines could help do away with misleading safety comparisons ... reporting patient safety data on their Web sites. While this ...
Cached Medicine News:Health News:FDA Grants Kiadis Pharma Lead Product ATIR Orphan Drug Designation 2Health News:FDA Grants Kiadis Pharma Lead Product ATIR Orphan Drug Designation 3Health News:Blood pressure drug curbs brain damage from PTSD 2Health News:CV Therapeutics Reports 2007 Third Quarter Financial Results 2Health News:CV Therapeutics Reports 2007 Third Quarter Financial Results 3Health News:CV Therapeutics Reports 2007 Third Quarter Financial Results 4Health News:CV Therapeutics Reports 2007 Third Quarter Financial Results 5Health News:CV Therapeutics Reports 2007 Third Quarter Financial Results 6Health News:CV Therapeutics Reports 2007 Third Quarter Financial Results 7Health News:CV Therapeutics Reports 2007 Third Quarter Financial Results 8Health News:Raleigh in National Study, Shows Survival to Hospital Discharge After Cardiac Arrest Doubles With Improved CPR and Impedance Threshold Device 2Health News:Raleigh in National Study, Shows Survival to Hospital Discharge After Cardiac Arrest Doubles With Improved CPR and Impedance Threshold Device 3
For restriction digests, immuno-precipitations, enzyme assays, TLC spotting and others...
... to order tips. Each box contains 10,000 ... available in easy-to-open, re-sealable Bulk Packs of ... sealed with a tamper-proof strip which can ... Gilsons Diamond Tips. Bulk Packs are closed ...
... tips. Each box contains 1000 tips (5 bags ... tips (4 bags of 50 tips). Also available ... per pack. Bulk Packs are sealed with a ... quick access to Gilsons Diamond Tips. Bulk Packs ...
Capillary section fits into a 0.3-mm well for accurate loading of sequencing gels - Ideal for use with CastAway System...
Medicine Products: